Eylea Safety and Effectiveness for Neovascular Glaucoma

This study is focused on understanding how safe and effective the drug Eylea is for treating Neovascular Glaucoma, a serious eye condition that can lead to vision loss. The study involves patients who have already been diagnosed with this condition and whose doctors have chosen Eylea as part of their treatment plan. The main goal is to gather real-world information about how patients respond to Eylea over time, which can help improve future treatment options and care for those affected by this type of glaucoma. Participants in the study will receive Eylea as part of their regular treatment and will be monitored for six months. During this time, researchers will collect detailed information at the start, during regular follow-up visits, and at the end of the study. The primary focus is on recording any adverse events, which are any unexpected problems or side effects that occur during treatment. This information is crucial for determining how safe Eylea is for patients in everyday clinical settings.